The 3 best biotech shares for 2016

CSL Limited (ASX:CSL), Sirtex Medical Limited (ASX:SRX) and Mayne Pharma Group Ltd (ASX:MYX) could continue their positive momentum.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As investors look back and review the 12 months of 2015 there are certainly a number of highlights, but also plenty of lowlights too!

The performance of the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) rates a mention as a lowlight for its fall of 7% year to date (YTD).

Likewise, the weak performance of bank stocks and Telstra Corporation Ltd (ASX: TLS) does too.

Then of course there are the resource and energy sectors which have seen a wipe-out in the share prices of many widely-held stocks such as BHP Billiton Limited (ASX: BHP) and Santos Ltd (ASX: STO) on account of plunging commodity prices.

Like I said, there have been some highlights though…

  • CSL Limited (ASX: CSL) continued its steady, dependable performance to gain 16% (YTD) to trade above the $100 mark
  • Sirtex Medical Limited (ASX: SRX) recovered from a bout of significant volatility in March to add around 40%
  • Mayne Pharma Group Ltd (ASX: MYX) soared 110% as the company implemented its US-led growth strategy

It's not the first time that healthcare sector stocks have performed well and displayed defensive characteristics.

With the outlook for 2016 remaining murky and the index recently touching a two-and-a-half-year low, defensive healthcare stocks could once again be set to perform well in 2016. In the the specific cases of CSL, Sirtex and Mayne, all three companies continue to expand their global footprints and enjoy growth opportunities in their respective businesses.

These growth profiles are at least in part thanks to research and development programs that have provided the firms with high-quality intellectual property (IP) assets to market, which stands CSL, Sirtex and Mayne in good stead to continue to have strong underlying business performance in 2016.

Motley Fool contributor Tim McArthur has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »